Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
BMJ Case Reports|October 4, 2018
First-line ibrutinib for Bing-Neel syndromeAaron Tallant, Daniel Selig, Sam O Wanko, et al.The Oncologist|August 2, 2006
Hairy cell leukemia: an elusive but treatable diseaseSam O Wanko, Carlos de CastroHematology/Oncology Clinics of North America|October 11, 2005
Transfusion management in sickle cell diseaseSam O Wanko, Marilyn J TelenBlood Reviews|March 24, 2005
Non-pharmacologic approaches to graft-versus-host preventionSam O Wanko, Nelson J ChaoBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2006
Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acidSam O Wanko, Gloria Broadwater, Rodney J Folz, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 24, 2018
Azacitidine-associated pleuropericardial effusion in myelodysplastic syndrome: A case reportKelli Goo, Rosalynda Uy, Joseph RoswarskiInternational Journal of Surgery Case Reports|April 9, 2016
Spontaneous pneumoperitoneum in pediatric patients: A case seriesCaitlin Tallant, Aaron Tallant, Jason Nirgiotis, et al.Vaccine|August 3, 2014
Relative cost-effectiveness of a norovirus vaccine in the deployed military setting compared to a vaccine against Campylobacter sp., ETEC, and Shigella spAaron Tallant, Chad K Porter, Shannon D Putnam, et al.Leukemia & Lymphoma|January 11, 2019
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomasJoseph Roswarski, Mark Roschewski, Christopher Melani, et al.Vaccine|February 6, 2020
Application of a cost-effectiveness analysis of pathogen-specific vaccines against gastroenteritis to a military population in a developing country settingSarah-Blythe Ballard, Aaron Tallant, Rosio G Guerra, et al.Pageof 2